Atherosclerosis
Volume 191, Issue 1 , Pages 63-72 , March 2007

Identifying leukocyte gene expression patterns associated with plasma lipid levels in human subjects

Received 3 January 2006 ,Revised 22 March 2006 ,Accepted 3 May 2006.

References 

  1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349:1436–1442
  2. Braunwald E. Shattuck lecture—cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997;337:1360–1369
  3. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. Thirty years of follow-up from the Framingham study. JAMA. 1987;257:2176–2180
  4. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361, 662 men. Lancet. 1986;2:933–936
  5. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol. 2000;86:943–949
  6. Young CE, Karas RH, Kuvin JT. High-density lipoprotein cholesterol and coronary heart disease. Cardiol Rev. 2004;12:107–119
  7. Assmann G, Gotto AM. HDL cholesterol and protective factors in atherosclerosis. Circulation. 2004;109(S1):III8–III14
  8. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109(S1):II2–II10
  9. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868–874
  10. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143
  11. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–126
  12. Elkind MS, Sciacca R, Boden-Albala B, Homma S, Di Tullio MR. Leukocyte count is associated with aortic arch plaque thickness. Stroke. 2002;33:2587–2592
  13. Huang ZS, Jeng JS, Wang CH, Yip PK, Wu TH, Lee TK. Correlations between peripheral differential leukocyte counts and carotid atherosclerosis in non-smokers. Atherosclerosis. 2001;158:431–436
  14. Elkind MS, Cheng J, Boden-Albala B, Paik MC, Sacco RL. Northern Manhattan Stroke Study. Elevated white blood cell count and carotid plaque thickness: the northern Manhattan stroke study. Stroke. 2001;32:842–849
  15. Ikata J, Wakatsuki T, Oishi Y, Oki T, Ito S. Leukocyte counts and concentrations of soluble adhesion molecules as predictors of coronary atherosclerosis. Coron Artery Dis. 2000;11:445–449
  16. Labarrere CA, Zaloga GP. C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am J Med. 2004;117(7):499–507
  17. Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med. 2004;116(Suppl. 6A):9S–16S
  18. Calvano SE, Xiao W, Richards DR, et al. A network-based analysis of systemic inflammation in humans. Nature. 2005;437(7061):1032–1037
  19. Wettinger SB, Doggen CJ, Spek CA, Rosendaal FR, Reitsma PH. High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells. Blood. 2005;105(5):2000–2006
  20. Van Oostrom AJ, Sijmonsma TP, Rabelink TJ, Van Asbeck BS, Cabezas MC. Postprandial leukocyte increase in healthy subjects. Metabolism. 2003;52:199–202
  21. Van Oostrom AJ, Sijmonsma TP, Verseyden C, et al. Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res. 2003;44:576–583
  22. Van Oostrom AJ, Rabelink TJ, Verseyden C, et al. Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis. 2004;177:175–182
  23. Brazma A, Hingamp P, Quackenbush J, Sherlock G, et al. Minimum information about a microarray experiment (MIAME)—toward standards for microarray data. Nature Genet. 2001;29:365–371
  24. Wu Z, LeBlanc R, Irizarry RA. Stochastic models based on molecular hybridization theory for short oligonucleotide microarrays technical report. Johns Hopkins University. Department of Biostatistics Working Papers; 2003.
  25. Whitney AR, Diehn M, Popper SJ, et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA. 2003;100:1896–1901
  26. Pandey R, Guru RK, Mount DW. Pathway Miner: extracting gene association networks from molecular pathways for predicting the biological significance of gene expression microarray data. Bioinformatics. 2004;20:2156–2158
  27. Wang X, Paigen B. Genetics of variation in HDL cholesterol in humans and mice. Circ Res. 2005;96:27–42
  28. Wang X, Paigen B. Genome-wide search for new genes controlling plasma lipid concentrations in mice and humans. Curr Opin Lipidol. 2005;16:127–137
  29. Ma J, Liew CC. Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease. J Mol Cell Cardiol. 2003;35:993–998
  30. Morello F, de Bruin TWA, Rotter JI, et al. Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 2004;24:2149–2154
  31. Hubner N, Wallace CA, Zimdahl H, et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet. 2005;37:243–253
  32. Wahli W, Braissant O, Desvergne B. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more. Chem Biol. 1995;2:261–266
  33. Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol. 2001;169:453–459
  34. Elangbam CS, Tyler RD, Lightfoot RM. Peroxisome proliferator-activated receptors in atherosclerosis and inflammation—an update. Toxicol Pathol. 2001;29:224–231

PII: S0021-9150(06)00257-7

doi: 10.1016/j.atherosclerosis.2006.05.032

Atherosclerosis
Volume 191, Issue 1 , Pages 63-72 , March 2007

Article Tools

* Image Usage & Resolution